Matthew Gline owns 2.30% of Roivant Sciences
16,583,774 shares as of the September 30, 2026 filing, worth $556M at the latest close.
ROIV · $24.2B market capGet an email when Matthew Gline’s stake moves.
Free.
The stake
2.30%
worth $556M at the latest close
Stake rank
#149
by dollar value of the stake
Last sale
186 days ago
Apr 16, 2026
Last buy
396 days ago
Sep 18, 2025 · $49,957
Matthew Gline owns 2.30% of Roivant Sciences Ltd.: 16,583,774 of 722,323,015 shares, worth about $556M at the 2026-10-16 close. The stake has moved from 0.76% in 2021 to 2.30% on 2026-09-30, across 13 sales and 1 purchase that moved it since 2016. The last trade that moved it was a discretionary sale of $8.4M on 2026-04-16.
How the stake is held
as of the Sep 30, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Sep 30, 2026 · Form 4 ↗
HELD DIRECTLY
16,583,774
100.0%
THE STAKE
16,583,774
2.30%